acute hipertension & hepatites.b blood vomit six times e

[Udai1]

my report as under:-
Dr. Lal Pathlabs Pvt. Ltd.

S36-LPL-LUCKNOW
8, MANDIR MARG,
MAHANAGAR EXTENTION,
MAHANAGAR EXTN.
LUCKNOW 226001
Dr_ Lal Pathlabs Pvt_ Ltd_files/lalpathlabs
Dr_ Lal Pathlabs Pvt_ Ltd_files/lalpathlabs

CLOSE

table with 4 columns and 3 rows
Name  : DR UDAY NARAYAN SINHA
Collected :      17/12/10 13:18  
Lab No  : 10 8244710
Age : 56 years
Gender : M
Received :      17/12/10 13:19 
A/C Status : C   Ref. By : DR.A.K.VAISH
Printed :         18/12/10 11:41
table end

        Test Name                         Result    Units    Ref. Range    Hemoglobin;Hb                           10.50    g/dL     (13.00 - 17.00)  BLOOD
PICTURE; PERIPHERAL BLOOD SMEAR EXAMINATION  Blood Picture                         Dimorphic  RBC picture with                                       microcytic
hypochromic                                       RBCs and macrocytes.                                       Anisocytosis ++,                        
             TLC and DLC are within normal                                       limits.                                       WBCs are normal in number
and                                       morphology.                                       No abnormal/immature cells seen                          
           .                                       Platelets are adequate.                                       No Hemoparasites seen                
                      Advised:                                       Correlation with clinical                                       details  HEPATITIS
B SURFACE ANTIGEN; HBsAg; AUSTRALIA ANTIGEN    @  Concentration                         250.00         IU/ml  ________________________________________________________________
|Interpretation:                                                 | |  Concentration             0.05 IU/ml     Reactive         | |________________________________________________________________| Comments: This assay  detects the
first  serological marker of  Hepatitis B as early as 4-16 weeks after exposure. It persists during acute illness and  disappears 12-20 weeks after onset
of symptoms. The titers rise rapidly during the  period of  viral replication  and  is frequently associated  with infectivity. Persistence  of HBsAg for
more  than 6 months indicates development of carrier state or chronic liver disease. Uses    * Routine screening of blood and blood products to prevent
     transmission of Hepatitis B virus (HBV) to recipients    * To diagnose suspected HBV infection and monitor the status of      infected individuals
   * To evaluate the efficacy of antiviral drugs    * For Prenatal Screening of pregnant women False Reactivity may be observed under the following circumstances:
   * Non repeatable reactives:  These are due to particulate matter      particularly fibrin, clots and cellular material in patient      sample    * Non
specific reactives: All highly sensitive immunoassay systems      have a potential for nonspecific reactions. This can be elimina-      ted by confirming
the result by the Neutralization Test  Liver Panel, Screen  SGOT (AST)                              66.00    U/L      (15.00 - 35.00) SGPT (ALT)      
                       97.00    U/L      (30.00 - 65.00) Alkaline Phosphatase (ALP)             102.00    U/L      (50.00 - 136.00) Bilirubin, Total  
                      0.90    mg/dL    (0.20 - 1.00) Bilirubin, Direct                        0.27    mg/dL    (< 0.21) Bilirubin, Indirect          
          0.63    mg/dL    (< 0.70) Protein, Total                           8.10    g/dL     (6.40 - 8.20) Albumin                                  4.20
   g/dL     (3.40 - 5.00) A : G Ratio                              1.08             (0.90 - 2.00)  Prothrombin Time Studies    @  Mean Normal Prothrombin
Time            13.20    sec On Patients Blood                       13.90    sec      (10.80 - 15.60) Prothrombin Ratio (PR)                   1.05 International
Normalized Ratio (INR)     1.07 Comments: International Normalized Ratio(INR) is the most recommended method for monitoring  of  oral anticoagulants. The
dose of anticoagulant  can be adjusted between the limits by two parallel biological assays: 1. Prothrombin time:  which explores the extrinsic coagulation
pathway 2. Activated partial thromboplastin time: which takes into account any    effect of deficiencies induced by the drug on the intrinsic pathway Therapeutic
Ranges: ---------------------------------------------------------------------- INDICATION                               RECOMMENDED THERAPEUTIC RANGE
                                                     INR ---------------------------------------------------------------------- Deep vein thrombosis  
                  2.0 - 3.0 Pulmonary embolism Arterial disease including Myocardial infarction ----------------------------------------------------------------------
Artificial cardiac valves                3.0 - 4.5 Recurrent systemic embolism ---------------------------------------------------------------------- The
common causes of prolonged Prothrombin Time are: Administration of oral anticoagulant drugs (Vitamin K antagonists)   1. Liver disease, particularly obstructive.
  2. Vitamin K deficiency   3. DIC   4. Rarely, a previously undiagnosed Factor VII, X, and V or      Prothrombin deficiency or defect. REPORT AUTHORIZED
BY:- Dr. Pankaj Sharma - HOD Coagulation Dr. Nimmi Kansal - HOD Biochemistry @ Dr. Sharvan Kumar Tripathi - Chief of Lab, Lucknow   REPORT COMPLETED  Tests
Requested: HEMOGLOBIN; Hb, BLOOD PICTURE/PERIPHERAL, HBS AG SCREEN#, LIVER PANEL, SCREEN, PROTHROMBIN TIME STUDIES, COMMENTS                          
      -*-
nnewfile2
nnewfile2
Dr_ Lal Pathlabs Pvt_ Ltd_files/lalpathlabs

[patient915]

I does not appear that you already posted these question.  The report suggests acute (short-lived) Hepatitis B.  From what I've read, most people do not need any treatment for acute Hep. B and it will clear on its own.  You should ask your doctor if in your particular case you need to do anything specific.

[Udai1]

please reply me, as i had already posted these question? irony! no reply received.

[patient915]

Welcome to the gastroenterology community!  What is your question?